Current state of diagnostic, screening and surveillance testing methods for COVID-19 from an analytical chemistry point of view DOI Open Access
Julia Martı́n, Noelia Tena, Agustín G. Asuero

et al.

Microchemical Journal, Journal Year: 2021, Volume and Issue: 167, P. 106305 - 106305

Published: April 19, 2021

Language: Английский

A Comprehensive Review of COVID-19 Virology, Vaccines, Variants, and Therapeutics DOI Creative Commons

Lauren Forchette,

William Sebastian,

Tuoen Liu

et al.

Current Medical Science, Journal Year: 2021, Volume and Issue: 41(6), P. 1037 - 1051

Published: July 9, 2021

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative pathogen of disease 2019 (COVID-19), has caused more than 179 million infections and 3.8 deaths worldwide. Throughout past year, multiple vaccines have already been developed used, while some others are in process being developed. However, emergence new mutant strains SARS-CoV-2 that demonstrated immune-evading characteristics an increase infective capabilities leads to potential ineffectiveness against these variants. The purpose this review article is highlight current understanding immunological mechanisms virus vaccines, as well investigate key variants mutations driving pandemic their impacts on management guidelines. We also discussed technologies for prevention, treatment, detection SARS-CoV-2. In paper, we thoroughly reviewed provided crucial information virology, drugs used its prevention important variant strains. Our paper will be beneficial health care professionals researchers so they can a better basic sciences, clinical treatment COVID-19 during pandemic. This consists most updated available June 21, 2021.

Language: Английский

Citations

233

Point-of-care COVID-19 diagnostics powered by lateral flow assay DOI Open Access

Yaofeng Zhou,

Yuhao Wu,

Lu Ding

et al.

TrAC Trends in Analytical Chemistry, Journal Year: 2021, Volume and Issue: 145, P. 116452 - 116452

Published: Oct. 4, 2021

Language: Английский

Citations

145

CRISPR-Cas systems for diagnosing infectious diseases DOI Open Access
Anastasiya Kostyusheva, Sergey Brezgin, Yu.Yu. Babin

et al.

Methods, Journal Year: 2021, Volume and Issue: 203, P. 431 - 446

Published: April 9, 2021

Language: Английский

Citations

120

A novel fluorescence biosensor based on CRISPR/Cas12a integrated MXenes for detecting Aflatoxin B1 DOI Creative Commons
Zhihui Wu, Da‐Wen Sun, Hongbin Pu

et al.

Talanta, Journal Year: 2022, Volume and Issue: 252, P. 123773 - 123773

Published: Aug. 6, 2022

Aflatoxin B1 (AFB1) contamination in food threatens global safety, and rapid quantitative detection of AFB1 remains a challenge. Herein, novel fluorescence biosensor was developed for based on CRISPR/Cas12a MXenes. Specifically, the well-designed activator locked by dual-AFB1 aptamers, Cas12a directly linked to crRNA form inactivated complexes, MXenes efficiently adsorbed FAM fluorophore-modified single-stranded DNA (ssDNA-FAM), quenching its fluorescence. In presence AFB1, released due preferential binding aptamer then activated trans-cleavage activity indiscriminately cleave ssDNA MXenes, leading recovery signal. The fluorescent had wide range from 0.001 80 ng mL-1, limit 0.92 pg ability detect within min. More importantly, platform demonstrates excellent performance real peanut samples.

Language: Английский

Citations

94

CRISPR-Cas for genome editing: Classification, mechanism, designing and applications DOI

Simran Bhatia,

P Pooja,

Sudesh Kumar Yadav

et al.

International Journal of Biological Macromolecules, Journal Year: 2023, Volume and Issue: 238, P. 124054 - 124054

Published: March 17, 2023

Language: Английский

Citations

84

Advancement in COVID‐19 detection using nanomaterial‐based biosensors DOI Creative Commons

Phuoc Loc Truong,

Yiming Yin, Daeho Lee

et al.

Exploration, Journal Year: 2023, Volume and Issue: 3(1)

Published: Jan. 7, 2023

Coronavirus disease 2019 (COVID-19) pandemic has exemplified how viral growth and transmission are a significant threat to global biosecurity. The early detection treatment of infections is the top priority prevent fresh waves control pandemic. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) been identified through several conventional molecular methodologies that time-consuming require high-skill labor, apparatus, biochemical reagents but have low accuracy. These bottlenecks hamper methods from resolving COVID-19 emergency. However, interdisciplinary advances in nanomaterials biotechnology, such as nanomaterials-based biosensors, opened new avenues for rapid ultrasensitive pathogens field healthcare. Many updated namely electrochemical, field-effect transistor, plasmonic, colorimetric employ nucleic acid antigen-antibody interactions SARS-CoV-2 highly efficient, reliable, sensitive, manner. This systematic review summarizes mechanisms characteristics biosensors detection. Moreover, continuing challenges emerging trends biosensor development also discussed.

Language: Английский

Citations

52

Colorimetric biosensing assays based on gold nanoparticles functionalized/combined with non-antibody recognition elements DOI
Hu Chen, Songtao Cai,

Jianxin Luo

et al.

TrAC Trends in Analytical Chemistry, Journal Year: 2024, Volume and Issue: 173, P. 117654 - 117654

Published: March 13, 2024

Language: Английский

Citations

17

Rapid PCR powered by microfluidics: A quick review under the background of COVID-19 pandemic DOI Open Access

Xiaobin Dong,

Luyao Liu,

Yunping Tu

et al.

TrAC Trends in Analytical Chemistry, Journal Year: 2021, Volume and Issue: 143, P. 116377 - 116377

Published: June 24, 2021

Language: Английский

Citations

100

Nanotechnology Against The Novel Coronavirus (Severe Acute Respiratory Syndrome Coronavirus 2): Diagnosis, Treatment, Therapy and Future Perspectives DOI
Hamid Rashidzadeh, Hossein Danafar, Hossein Rahimi

et al.

Nanomedicine, Journal Year: 2021, Volume and Issue: 16(6), P. 497 - 516

Published: March 1, 2021

COVID-19, as an emerging infectious disease, has caused significant mortality and morbidity along with socioeconomic impact. No effective treatment or vaccine been approved yet for this pandemic disease. Cutting-edge tools, especially nanotechnology, should be strongly considered to tackle virus. This review aims propose several strategies design fabricate diagnostic therapeutic agents against COVID-19 by the aid of nanotechnology. Polymeric, inorganic self-assembling materials peptide-based nanoparticles are promising tools battling well its rapid diagnosis. summarizes all exciting advances nanomaterials making toward prevention, diagnosis therapy.

Language: Английский

Citations

71

Detection of SARS-CoV-2 and its S and N proteins using surface enhanced Raman spectroscopy DOI Creative Commons
John E. Sanchez,

Sierra A. Jaramillo,

Erik W. Settles

et al.

RSC Advances, Journal Year: 2021, Volume and Issue: 11(41), P. 25788 - 25794

Published: Jan. 1, 2021

The COVID-19 pandemic demonstrated the critical need for accurate and rapid testing virus detection. This has generated a high number of new methods aimed at replacing RT-PCR, which is golden standard testing. Most techniques are based on biochemistry require chemicals that often expensive supply might become scarce in large crisis. In present paper we suggest use physics leverage novel nanomaterials. We demonstrate using Surface Enhanced Raman Spectroscopy (SERS) virion particles very distinct spectroscopic signature SARS-CoV-2 can be obtained. spectra mainly composed by signals from spike (S) nucleocapsid (N) proteins. It believed clinical test SERS developed. will fast, inexpensive, reliable. also clear used analysis structural changes S N an example application nanotechnology properties nanoparticles health social related matters.

Language: Английский

Citations

70